Gösta Dahlén

3.9k total citations · 1 hit paper
31 papers, 3.2k citations indexed

About

Gösta Dahlén is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gösta Dahlén has authored 31 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gösta Dahlén's work include Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cancer, Lipids, and Metabolism (5 papers). Gösta Dahlén is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cancer, Lipids, and Metabolism (5 papers). Gösta Dahlén collaborates with scholars based in Sweden, Norway and United States. Gösta Dahlén's co-authors include Kåre Berg, Margareta Blombäck, Anders Hamsten, Björn Wiman, Göran Walldius, U de Faire, Alfred Szamosi, Christian Landou, Anne‐Lise Børresen and Mats Frick and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Gösta Dahlén

31 papers receiving 3.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

1987 1.3k citations Gösta Dahlén et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gösta Dahlén Sweden	20	1.3k	960	852	766	538	31	3.2k
G. Dahlén Sweden	27	2.3k 1.9×	1.4k 1.5×	991 1.2×	929 1.2×	410 0.8×	64	3.8k
F. Haverkate Netherlands	32	770 0.6×	541 0.6×	1.1k 1.3×	647 0.8×	899 1.7×	94	4.7k
Vivian P. Thompson United States	17	690 0.6×	1.5k 1.6×	579 0.7×	343 0.4×	710 1.3×	22	3.6k
Justo Aznar Spain	30	405 0.3×	311 0.3×	745 0.9×	277 0.4×	252 0.5×	121	2.9k
Trent Tracy United States	34	1.2k 1.0×	649 0.7×	395 0.5×	176 0.2×	166 0.3×	53	3.2k
Bruce A. Kottke United States	27	1.1k 0.9×	906 0.9×	483 0.6×	263 0.3×	382 0.7×	82	2.4k
Wolfgang Speiser Austria	32	548 0.4×	212 0.2×	1.1k 1.3×	159 0.2×	403 0.7×	90	3.6k
G Turpin France	27	905 0.7×	1.6k 1.7×	428 0.5×	189 0.2×	1.2k 2.2×	127	3.2k
Shih-Jen Hwang United States	21	533 0.4×	368 0.4×	572 0.7×	467 0.6×	598 1.1×	27	4.3k
Piet Meijer Netherlands	28	581 0.5×	263 0.3×	379 0.4×	156 0.2×	299 0.6×	143	2.7k

Countries citing papers authored by Gösta Dahlén

Since Specialization

Citations

This map shows the geographic impact of Gösta Dahlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gösta Dahlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gösta Dahlén more than expected).

Fields of papers citing papers by Gösta Dahlén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gösta Dahlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gösta Dahlén. The network helps show where Gösta Dahlén may publish in the future.

Co-authorship network of co-authors of Gösta Dahlén

This figure shows the co-authorship network connecting the top 25 collaborators of Gösta Dahlén. A scholar is included among the top collaborators of Gösta Dahlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gösta Dahlén. Gösta Dahlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thøgersen, Anna Margrethe, Stefan Söderberg, Jan‐Håkan Jansson, et al.. (2004). Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction. European Journal of Cardiovascular Prevention & Rehabilitation. 11(1). 33–40. 37 indexed citations

Thøgersen, Anna Margrethe, Torbjörn Nilsson, Gösta Dahlén, et al.. (2001). Homozygosity for the C 677 →T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden. Coronary Artery Disease. 12(2). 85–90. 19 indexed citations

Thorsen, K., Peter Nordström, Ronny Lorentzon, & Gösta Dahlén. (1999). The Relation between Bone Mineral Density, Insulin-Like Growth Factor I, Lipoprotein (a), Body Composition, and Muscle Strength in Adolescent Males. The Journal of Clinical Endocrinology & Metabolism. 84(9). 3025–3029. 17 indexed citations

Larsson, Lill‐Inger, Albert Alm, Folke Lithner, Gösta Dahlén, & Reinhold Bergström. (1999). The association of hyperlipidemia with retinopathy in diabetic patients aged 15‐50 years in the county of Umeå. Acta Ophthalmologica Scandinavica. 77(5). 585–591. 35 indexed citations

Berg, Kåre, Gösta Dahlén, Bjørn O. Christophersen, et al.. (1997). Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study. Clinical Genetics. 52(5). 254–261. 121 indexed citations

Jonasson, Lena, et al.. (1997). Lipoprotein(a) and HLA-DRB1 and -DQB1 genes in coronary artery disease. Atherosclerosis. 133(1). 111–114. 18 indexed citations

Dahlén, Gösta & Hans Stenlund. (1997). Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance. Clinical Genetics. 52(5). 272–280. 47 indexed citations

Wållberg‐Jonsson, Solveig, Gösta Dahlén, Owe Johnson, Gunilla Olivecrona, & Solbritt Rantapää‐Dahlqvist. (1996). Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis. Journal of Internal Medicine. 240(6). 373–380. 21 indexed citations

Dahlén, Gösta, Jens Boman, Lisbeth Slunga Birgander, & Bertil Lindblom. (1995). Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis. 114(2). 165–174. 98 indexed citations

10.

Porkka, Kimmo, Risto Erkkola, Simo Taimela, et al.. (1995). Influence of Oral Contraceptive Use on Lipoprotein (a) and Other Coronary Heart Disease Risk Factors. Annals of Medicine. 27(2). 193–198. 23 indexed citations

11.

Hong, Yuling, Gösta Dahlén, Nancy L. Pedersen, et al.. (1995). Potential environmental effects on adult lipoprotein(a) levels: results from Swedish twins. Atherosclerosis. 117(2). 295–304. 15 indexed citations

12.

Dahlén, Gösta. (1994). Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis. 108(2). 111–126. 187 indexed citations

13.

Dahlén, Gösta, et al.. (1994). Importance of Lp(a) lipoprotein and HLA genotypes in atherosclerosis and diabetes. Clinical Genetics. 46(1). 46–51. 25 indexed citations

14.

Heller, Debra A., et al.. (1993). Genetic and Environmental Influences on Serum Lipid Levels in Twins. New England Journal of Medicine. 328(16). 1150–1156. 374 indexed citations

15.

Sundell, Birgitta, Gösta Dahlén, & Mats Rånby. (1991). Diet-Induced Changes in Glucose and Triglycerides Are Associated with Changes in Plasminogen Activator Inhibitor Levels. Pathophysiology of Haemostasis and Thrombosis. 21(3). 175–180. 11 indexed citations

16.

Norrgård, Örjan, Karl‐Axel Ängquist, & Gösta Dahlén. (1991). Lp(a) lipoprotein in patients with arterial insufficiency of the lower extremities. European Journal of Vascular Surgery. 5(3). 277–282. 15 indexed citations

17.

Asplund, Kjell, Tommy Olsson, Matti Viitanen, & Gösta Dahlén. (1991). Lp(a) Lipoprotein in Patients with Acute Stroke. Cerebrovascular Diseases. 1(2). 90–96. 14 indexed citations

18.

Theorell, Töres, et al.. (1980). A Comparison between Finnish Immigrants and Native Swedes in the Greater Stockholm Region—Social and Medical Risk Indicators of Ischemic Heart Disease. Scandinavian Journal of Social Medicine. 8(3). 105–115. 9 indexed citations

19.

Berg, Kåre, Gösta Dahlén, & Mats Frick. (1974). Lp(a) lipoprotein and pre‐β₁‐lipoprotein in patients with coronary heart disease. Clinical Genetics. 6(3). 230–235. 261 indexed citations

20.

Dahlén, Gösta, et al.. (1974). PRE‐β‐1 LIPOPROTEIN AND EARLY DETECTION OF RISK FACTORS FOR CORONARY HEART DISEASE. Acta Medica Scandinavica. 195(1-6). 341–344. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact